Aegle Therapeutics
Phase 1/2Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of those
Founded
2015
Focus
Biologics
About
Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of those
Funding History
2Total raised: $10.5M
Series A$8MUndisclosedMar 15, 2020
Seed$2.5MUndisclosedMay 15, 2018
Company Info
TypePrivate
Founded2015
LocationMiami, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile